Kimberly C Bentjen, DDS, MD | |
200 1st St Sw, Rochester, MN 55905-0001 | |
(507) 284-2511 | |
Not Available |
Full Name | Kimberly C Bentjen |
---|---|
Gender | Female |
Speciality | Oral & Maxillofacial Surgery |
Location | 200 1st St Sw, Rochester, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144459587 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Kimberly C Bentjen, DDS, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Kimberly C Bentjen, DDS, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
Medical marijuana users who say they have high levels of pain are more likely than those with low pain to say they use cannabis three or more times a day, a new study finds.
Putting an end to the search for a tool that will allow orthopaedic surgeons craft patient-specific solutions to extraordinary cases, Materialise is announcing the launch of SurgiCase(R) Orthopaedics. It's a comprehensive service that centers on the use of CT/MRI images in virtual surgical planning, the construction of cutting and drill guides individualized to fit the patient, and physical patient models.
A team led by scientists at The Scripps Research Institute (TSRI) has identified a family of tiny RNA molecules that work as powerful regulators of the immune response in mammals. Mice who lack these RNA molecules lose their normal infection-fighting ability, whereas mice that overproduce them develop a fatal autoimmune syndrome.
As the war on HIV/AIDS begins its fourth decade, medical researchers, pharmaceutical manufacturers, patient advocates and government regulators face a new and unexpected scientific challenge: how to demonstrate the safety and efficacy of promising new antiretroviral drugs when the two traditional study designs – the superiority trial and the non-inferiority trial – are no longer useful in showing improvements in both "treatment experienced" patients and those who have never received drug therapy (treatment-naive patients).
› Verified 4 days ago